PCT: Post-Cycle Therapy Complete Guide
Last updated: October 2026
Post-cycle therapy (PCT) is a protocol, commonly run for 4–8 weeks in community regimens, using SERMs like enclomiphene or tamoxifen to restart the hypothalamic-pituitary-gonadal (HPG) axis after suppressive compounds such as SARMs. User reports describe natural testosterone staying suppressed for months after heavier or longer cycles without PCT, with fatigue, muscle loss, low libido and low mood; how long suppression lasts is not well studied. PCT aims to help LH and testosterone return toward baseline; how fast that happens varies by compound, dose and cycle length.
PCT Length
and Hormone Cycles
Still logging injections in your Notes app?
A notes thread can't show a missed day at a glance, because it's a list, not a calendar. A printed log can. Your compounds and dates filled in: injection log, weekly schedule, dated calendar. Free to build and preview; $5/month to unlock printing.
Why PCT Is Needed
SARMs and anabolic compounds work by binding androgen receptors, but that same mechanism signals the brain to stop making natural testosterone. Recovery depends on understanding this feedback loop.
When androgens (SARMs or exogenous testosterone) activate androgen receptors, the hypothalamus detects elevated androgen signaling and reduces GnRH pulse frequency. This tells the pituitary to cut LH and FSH output, the hormones your testes need to function.
Without adequate LH stimulation, Leydig cells in the testes produce less testosterone. How long this lasts after stopping is not well studied: in the one cited controlled trial (LGD-4033, 21 days, low doses) hormone levels returned to baseline without PCT, while user reports describe longer suppression after heavier or longer cycles. Bloodwork is the only way to know where you stand.
Community-reported, not established by trials cited on this page: users describe fatigue, brain fog, low mood, loss of libido, loss of muscle gains, increased body fat, and poor sleep after a cycle. In the one cited controlled trial (LGD-4033, 21 days, low doses), fat mass did not change significantly and hormone levels returned to baseline after stopping.
SERMs block estrogen receptors at the hypothalamus and pituitary, reducing the negative feedback signal. The brain responds by increasing GnRH → LH/FSH surges → testicular testosterone production resumes. Recovery time varies; user reports describe months after heavy cycles.
When Is PCT Required?
Not all SARMs suppress equally. Below is how these compounds are commonly ranked. For several of them controlled human data are missing or minimal, so the rankings mostly reflect user reports, not trials.
PCT Compounds Compared
All three SERM options are meant to work by blocking estrogen receptors at the hypothalamus/pituitary, prompting LH and FSH release. They differ in available data. The doses on these cards are community-reported figures, not from a source cited on this page; dosing is for your prescriber.
The trans-isomer of clomiphene, without the zuclomiphene component. Like other SERMs, it is meant to raise LH and testosterone by blocking estrogen feedback. No head-to-head trials show it has fewer side effects than Clomid.
- Single isomer (no zuclomiphene)
- Oral, once daily
- Less data than Nolvadex
- Not FDA approved
- E2 rise reported
- Less available
A long-established SERM; its decades of clinical data come mostly from breast cancer and other indications, not post-cycle use. A community-reported schedule (not from a source cited here) runs weeks 1-2 at 20-40mg, then a taper to 10-20mg for weeks 3-4. May act as a partial agonist in bone/liver.
- Decades of data
- Well-understood
- Raises LH (SERM mechanism)
- Available worldwide
- Hot flashes reported
- Mood changes reported
- Partial agonist effects
- Requires taper
Older option: a mixture of enclomiphene (active) and zuclomiphene (longer half-life). Community reports often blame zuclomiphene for side effects, but no head-to-head PCT trials compare clomiphene with enclomiphene.
- Long track record
- Widely available
- Inexpensive
- Meant to raise LH (SERM mechanism)
- Side effects commonly reported
- Visual disturbances reported
- Mood changes reported
- Zuclomiphene lingers
HCG mimics LH and directly stimulates the testes, but it's NOT true PCT. It doesn't restart the HPG axis or pituitary signaling. Commonly used on-cycle to limit testicular shrinkage, or as a bridge before SERM PCT.
- Mimics LH directly
- Commonly used on-cycle
- Used to limit testicular shrinkage
- Not true PCT
- Injections required
- E2 rise reported
- Requires SERM follow-up
PCT Protocols
The start times below are community conventions keyed to each compound's half-life where one is known: roughly 1–2 half-lives after the last dose, not full clearance (about 4–5 half-lives). They are not timings established in clinical trials. The same goes for the dose and taper schedules: they are community-reported regimens, not protocols tested in trials of post-cycle use. SERMs require a prescription; dosing is for your prescriber to decide.
-
MKOstarine (MK-2866): no half-life citedCommunity protocols commonly start PCT 24-48 hours after last dose, but no Ostarine half-life is cited on this page, so this timing is a community convention, not half-life-derived.
-
LGDLGD-4033: long half-life (PMID 22459616)Community protocols commonly start PCT 48-72 hours after last dose. The cited trial reports a long half-life but did not study PCT timing, so this start time is a community convention, not trial-derived.
-
RADRAD-140: no human half-life citedCommunity protocols commonly wait 3-4 days after last dose before starting PCT, but no RAD-140 half-life is cited on this page, so this timing is a community convention, not half-life-derived.
-
YKYK-11: no human half-life dataCommunity protocols commonly start PCT 24-48hrs after last dose, but with no published human pharmacokinetic data this is a guess.
-
S23S-23: no human half-life dataNo published human pharmacokinetic data, so any start time is a guess.
Commonly used after compounds community-reported as milder (e.g., Ostarine). In the one cited trial, a short low-dose LGD-4033 cycle (21 days) recovered without PCT (PMID 22459616).Community-reported figures, not from a source cited on this page; dosing is for your prescriber.
-
W1-2Weeks 1–2: Full DoseEnclomiphene 25mg or Nolvadex 20mg or Clomid 50mg daily
-
W3-4Weeks 3–4: TaperEnclomiphene 12.5mg or Nolvadex 10mg or Clomid 25mg daily
Commonly used after compounds community-reported as heavier (RAD-140, longer or stacked LGD-4033 cycles; YK-11 and S-23 have no human data). The cited LGD-4033 trial tested only a short low-dose cycle, which recovered without PCT.Community-reported figures, not from a source cited on this page; dosing is for your prescriber.
-
W1-2Weeks 1–2: High DoseEnclomiphene 25mg or Nolvadex 40mg or Clomid 50mg
-
W3-5Weeks 3–5: ModerateEnclomiphene 12.5mg or Nolvadex 20mg or Clomid 25mg
-
W6-8Weeks 6–8: Taper OffEnclomiphene 12.5mg EOD or Nolvadex 10mg daily
Bloodwork Guide
Bloodwork is non-negotiable. It's the only way to confirm suppression, guide PCT timing, and verify recovery. Without it, you can't tell whether your levels have actually recovered.
What to Test
| Marker | Reference Range* | Why It Matters |
|---|---|---|
| Total Testosterone | Per your lab report | Primary measure of recovery. Should return to your pre-cycle baseline. |
| LH (Luteinizing Hormone) | Per your lab report | The signal from pituitary to testes. Low LH = HPG still suppressed. SERMs are meant to raise this. |
| FSH (Follicle-Stimulating Hormone) | Per your lab report | FSH stimulates Sertoli cells and spermatogenesis. Recovery indicator alongside LH. |
| Estradiol (E2) | Per your lab report | Should stay in range during PCT. Community guides commonly say elevated E2 can blunt PCT efficacy and cause sides; not established by trials cited on this page. |
| SHBG (Sex Hormone Binding Globulin) | Per your lab report | Binds testosterone, which affects free T availability. LGD-4033 lowered SHBG in the cited trial. |
*Reference ranges differ by lab and assay, so this page does not list numbers. Use the range printed on your own lab report and compare against your pre-cycle baseline.
Signs PCT Is Working
Recovery isn't instant. Below is a commonly reported week-by-week pattern. Individual timelines vary widely, and only bloodwork confirms recovery.
The SERM is meant to stimulate LH/FSH, but testosterone production takes time to respond. Fatigue, low libido, and mood dips are commonly reported here, and feeling low early does not by itself mean PCT is failing. Judge progress by bloodwork, not by how you feel in week 1.
Users commonly report energy improving, some libido returning, morning erections resuming and clearer thinking around this point. These can be encouraging signs, but they don't confirm recovery. Only bloodwork does. If you feel worse than week 1, get bloodwork: something may be off.
Users commonly report libido and mood moving back toward pre-cycle levels and strength holding steady. This is where a 4-week community regimen ends and post-PCT monitoring begins.
After heavy suppression, recovery may take this long or much longer. User reports describe months. Bloodwork is the only way to tell whether Total T, LH, and FSH are back at or near baseline. Feeling good doesn't equal recovered levels.
When TRT Becomes Necessary
Recovery after a cycle varies. For some, particularly those who've run multiple heavy cycles or had pre-existing low testosterone, natural recovery may not be achievable.
Commonly cited in community guides; no trial cited on this page defines a failure threshold: six weeks post-PCT with Total T still below your lab's reference range or well below your pre-cycle baseline. LH and FSH remain suppressed despite full SERM protocol. Persistent symptoms: fatigue, zero libido, depression, no morning erections. Low T at 6 weeks is a reason to see a specialist, not proof the axis won't recover. User reports describe recovery taking months.
Commonly cited in community guides; not established by trials cited on this page: multiple consecutive cycles without adequate time off. Heavy stacking (multiple suppressive SARMs). Cycles lasting 12+ weeks. Pre-existing low testosterone. Older age. Running compounds without bloodwork baseline.
TRT (testosterone replacement therapy) can restore quality of life for men who can't recover naturally. But it's usually a long-term commitment: exogenous testosterone suppresses your natural axis for as long as you take it, and recovery after stopping is not guaranteed. Think carefully before choosing this path.
See an endocrinologist or men's health specialist, not your GP. Bring bloodwork from pre-cycle, post-cycle, and post-PCT. Consider another SERM trial before committing to TRT. User reports describe recovery taking months after heavy cycles; no trial cited on this page measured recovery time after heavy cycles. Don't rush the TRT decision.
Want the full picture on TRT? Our Testosterone & TRT Complete Guide covers diagnosis criteria, protocol options (cypionate vs enanthate vs pellets), AI management, and fertility considerations for men on TRT long-term.
Key Takeaways
- PCT is commonly used after suppressive SARMs (RAD-140, LGD, YK-11, S-23) and hormone cycles
- Enclomiphene is popular in community PCT protocols, but no head-to-head trials show it has fewer side effects than Clomid
- Tamoxifen (Nolvadex) is a long-established SERM, though its clinical data come mostly from indications other than PCT
- PCT start time is commonly keyed to the compound's half-life
- Community PCT regimens commonly run 4 weeks, or 6-8 weeks after stronger compounds (no trial has established PCT length)
- Bloodwork is essential: get pre-cycle baseline, 2 weeks post-PCT, and 4–6 weeks post-PCT
- Commonly reported pattern: energy improving by week 3-4, libido and mood by week 4-6. Only bloodwork confirms recovery
- Cardarine (GW-501516) is not a SARM and isn't expected to be suppressive, but human data are minimal
- Skipping bloodwork and guessing: you can't manage what you don't measure
- Running HCG during PCT as a SERM substitute: HCG is not PCT
- Stopping PCT early because you feel "fine", yet T can still be suppressed
- Doing PCT without pre-cycle baseline: you don't know what "recovered" looks like
- Rushing into TRT after one failed PCT attempt: give recovery time
- Running back-to-back cycles without time for full HPG axis recovery
- Relying on "PCT supplements" like DAA or ashwagandha alone: no trial cited on this page shows they replace a SERM
Swiss Chems (affiliate partner)
Swiss Chems lists the three SERMs compared on this page: enclomiphene, tamoxifen and clomiphene. HighPeptides earns a commission on purchases. Lab-test standing and regulatory notices for every vendor we track, including this one, are on our vendors page.
Enclomiphene at Swiss Chems →Tamoxifen at Swiss Chems →Clomiphene at Swiss Chems →Affiliate links support HighPeptides at no extra cost.
PCT Support Supplements
Supplements some people take alongside PCT. None replaces a SERM, and no trial cited on this page shows any of them speeds post-cycle recovery.
Affiliate links support HighPeptides at no extra cost.
Related Resources
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 20+ compounds, all in one place.
Get the Guide: $19 (normally $29) →
The Peptide Buyer’s Playbook ($19)
This page is for educational and informational purposes only. It is not medical advice. SARMs are not FDA approved for human use and are illegal for sale as dietary supplements in the United States. Enclomiphene, tamoxifen, and clomiphene require a prescription. None of the information on this page constitutes medical advice or should be used to self-treat any condition. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or supplement protocol. Hormone management carries significant risks and should be supervised by a licensed physician.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.